Clinical trials
Phase 3 Anemia, Iron-Deficiency trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
84 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 5 |
| 2011 | 6 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 7 |
| 2017 | 6 |
| 2018 | 4 |
| 2019 | 7 |
| 2020 | 6 |
| 2021 | 7 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 55 |
| Recruiting | 8 |
| Unknown status | 8 |
| Terminated | 6 |
| Not yet recruiting | 4 |
| Withdrawn | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pharmacosmos A/S | 11 |
| AMAG Pharmaceuticals, Inc. | 9 |
| American Regent, Inc. | 5 |
| Shield Therapeutics | 5 |
| Vifor Pharma | 5 |
| Baylor College of Medicine | 2 |
| Zeria Pharmaceutical | 2 |
| AFT Pharmaceuticals, Ltd. | 1 |
| AHS Cancer Control Alberta | 1 |
| Alberta Health Services, Calgary | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Iron-Deficiency | 84 |
| Anemia | 24 |
| Iron Deficiencies | 22 |
| Renal Insufficiency, Chronic | 10 |
| Inflammatory Bowel Diseases | 8 |
| Colitis, Ulcerative | 4 |
| Crohn Disease | 4 |
| Heart Diseases | 2 |
| Heart Failure | 2 |
| Hyperphosphatemia | 2 |
Trials
Showing 76 to 84 of 84. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.